Cargando…
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
BACKGROUND: Radiotherapy has a high curative potential in localized prostate cancer, however, there are still patients with locally advanced tumours who face a considerable risk of recurrence. Radiosensitization using molecular targeted drugs could help to optimize treatment for this high-risk group...
Autores principales: | Liebscher, Steffi, Koi, Lydia, Löck, Steffen, Muders, Michael H., Krause, Mechthild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893532/ https://www.ncbi.nlm.nih.gov/pubmed/29657993 http://dx.doi.org/10.1016/j.ctro.2016.12.002 |
Ejemplares similares
-
Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015) -
The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020) -
New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
por: Antunes, Dinler A., et al.
Publicado: (2014) -
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
por: Koltai, Tomas
Publicado: (2015) -
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
por: Yamamoto, Norio, et al.
Publicado: (2004)